Parkinson's diseaseMARSDEN, C. D.Journal of neurology, neurosurgery and psychiatry. 1994, Vol 57, Num 6, pp 672-681, issn 0022-3050Article

Parkinson's disease in twinsMARSDEN, C. D.Journal of neurology, neurosurgery and psychiatry. 1987, Vol 50, Num 1, pp 105-106, issn 0022-3050Article

Parkinson's diseaseMARSDEN, C. D.Postgraduate medical journal. 1992, Vol 68, Num 801, pp 538-543, issn 0032-5473Article

Motor disorders in basal ganglia diseaseMARSDEN, C. D.Human neurobiology. 1984, Vol 2, Num 4, pp 245-250, issn 0721-9075Article

Bradykinesia and impairment of EEG desynchronization in Parkinson's diseaseBROWN, P; MARSDEN, C. D.Movement disorders. 1999, Vol 14, Num 3, pp 423-429, issn 0885-3185Article

A double blind trial of sulpiride in Huntington's disease and tardive dyskinesiaQUINN, N; MARSDEN, C. D.Journal of neurology, neurosurgery and psychiatry. 1984, Vol 47, Num 8, pp 844-847, issn 0022-3050Article

The stiff man and stiff man plus syndromesBROWN, P; MARSDEN, C. D.Journal of neurology. 1999, Vol 246, Num 8, pp 648-652, issn 0340-5354Article

What do the basal ganglia do?BROWN, P; MARSDEN, C. D.Lancet (British edition). 1998, Vol 351, Num 9118, pp 1801-1804, issn 0140-6736Article

Depression in torticollis: a controlled studyJAHANSHAHI, M; MARSDEN, C. D.Psychological medicine (Print). 1988, Vol 18, Num 4, pp 925-933, issn 0033-2917Article

Limb apraxias: Higher-order disorders of sensorimotor integrationLEIGUARDA, R. C; MARSDEN, C. D.Brain. 2000, Vol 123, pp 860-879, issn 0006-8950, 5Article

SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystoniaMATHEN, D; MARSDEN, C. D; BHATIA, K. P et al.Movement disorders. 1999, Vol 14, Num 5, pp 874-876, issn 0885-3185Article

Altered motor function and graft survival produced by basic fibroblast growth factor in rats with 6-OHDA lesions and fetal ventral mesencephalic grafts are associated with glial proliferationZENG, B.-Y; JENNER, P; MARSDEN, C. D et al.Experimental neurology (Print). 1996, Vol 139, Num 2, pp 214-226, issn 0014-4886Article

Mitochondrial respiratory enzyme function and superoxide dismutase activity following brain glutathione depletion in the ratSEATON, T. A; JENNER, P; MARSDEN, C. D et al.Biochemical pharmacology. 1996, Vol 52, Num 11, pp 1657-1663, issn 0006-2952Article

Neurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findingsLEE, M. S; MARSDEN, C. D.Movement disorders. 1994, Vol 9, Num 5, pp 550-558, issn 0885-3185Article

Autoradiographic study of striatal D₁ and D₂ dopamine receptors in 5-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-DOPA and carbidopaBLUNT, S. B; JENNER, P; MARSDEN, C. D et al.Brain research. 1992, Vol 582, Num 2, pp 299-311, issn 0006-8993Article

Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-DOPA and carbidopaBLUNT, S. B; JENNER, P; MARSDEN, C. D et al.Experimental brain research. 1992, Vol 88, Num 2, pp 326-340, issn 0014-4819Article

Dual task performance and processing resources in normal subjects and patients with Parkinson's diseaseBROWN, R. G; MARSDEN, C. D.Brain. 1991, Vol 114, pp 215-231, issn 0006-8950, 1AArticle

Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviourDAVIS, A; JENNER, P; MARSDEN, C. D et al.Psychopharmacologia. 1990, Vol 100, Num 1, pp 19-26, issn 0033-3158Article

Viewpoints on the Ramsay Hunt syndrome. I: the Ramsay hunt syndrome is a useful clinical entityMARSDEN, C. D; OBESO, J. A.Movement disorders. 1989, Vol 4, Num 1, pp 6-12, issn 0885-3185Article

Oxyferriscarbone elevates the total iron content of blood but not brainDEXTER, D. T; JENNER, P; MARSDEN, C. D et al.Movement disorders. 1989, Vol 4, Num 2, pp 176-182, issn 0885-3185, 7 p.Article

Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in ratsKELLY, E; JENNER, P; MARSDEN, C. D et al.Journal of pharmacy and pharmacology. 1987, Vol 39, Num 3, pp 196-202, issn 0022-3573Article

Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidylBURKE, R. E; FAHN, S; MARSDEN, C. D et al.Neurology. 1986, Vol 36, Num 2, pp 160-164, issn 0028-3878Article

The treatment of severe dystonia in children and adultsMARSDEN, C. D; MARION, M.-H; QUINN, N et al.Journal of neurology, neurosurgery and psychiatry. 1984, Vol 47, Num 11, pp 1166-1173, issn 0022-3050Article

Turnover of specific [³H] spiperone and [³H] N,n propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administrationHALL, M. D; JENNER, P; MARSDEN, C. D et al.Biochemical pharmacology. 1983, Vol 32, Num 19, pp 2973-2977, issn 0006-2952Article

Sleep benefit in Parkinson's diseaseBATEMAN, D. E; LEVETT, K; MARSDEN, C. D et al.Journal of neurology, neurosurgery and psychiatry. 1999, Vol 67, Num 3, pp 384-385, issn 0022-3050Article